T1	Participants 536 612	Adult and pediatric patients with allergic rhinoconjunctivitis and/or asthma
T2	Participants 641 653	Ten subjects
T3	Participants 710 730	Forty-three subjects
T4	Participants 1354 1389	patients with respiratory allergies
